Asthma - Pipeline Review, H2 2018

Asthma - Pipeline Review, H2 2018

Summary

The latest Pharmaceutical and Healthcare disease pipeline guide Asthma - Pipeline Review, H2 2018, provides an overview of the Asthma (Respiratory) pipeline landscape.

Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Asthma - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 3, 19, 42, 31, 2, 106, 26 and 1 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 29 and 8 molecules, respectively.

Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).
- The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.



Introduction 8
Asthma - Overview 9
Asthma - Therapeutics Development 10
Asthma - Therapeutics Assessment 38
Asthma - Companies Involved in Therapeutics Development 54
Asthma - Drug Profiles 112
Asthma - Dormant Projects 568
Asthma - Discontinued Products 594
Asthma - Product Development Milestones 600
Appendix 612


List Of Tables


Number of Products under Development for Asthma, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Products under Development by Companies, H2 2018
Products under Development by Universities/Institutes, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Asthma - Pipeline by 4D Pharma PLC, H2 2018
Asthma - Pipeline by AB Science SA, H2 2018
Asthma - Pipeline by AbbVie Inc, H2 2018
Asthma - Pipeline by Abeome Corp, H2 2018
Asthma - Pipeline by Accolade Pharmaceuticals LLC, H2 2018
Asthma - Pipeline by Adamis Pharmaceuticals Corp, H2 2018
Asthma - Pipeline by ALK-Abello AS, H2 2018
Asthma - Pipeline by Allergan Plc, H2 2018
Asthma - Pipeline by Allergopharma GmbH & Co KG, H2 2018
Asthma - Pipeline by Almirall SA, H2 2018
Asthma - Pipeline by Amgen Inc, H2 2018
Asthma - Pipeline by Amphastar Pharmaceuticals Inc, H2 2018
Asthma - Pipeline by AnaptysBio Inc, H2 2018
Asthma - Pipeline by AnGes Inc, H2 2018
Asthma - Pipeline by Antisense Therapeutics Ltd, H2 2018
Asthma - Pipeline by Apollo Endosurgery Inc, H2 2018
Asthma - Pipeline by ASIT Biotech SA, H2 2018
Asthma - Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2018
Asthma - Pipeline by Astellas Pharma Inc, H2 2018
Asthma - Pipeline by AstraZeneca Plc, H2 2018
Asthma - Pipeline by Aurigene Discovery Technologies Ltd, H2 2018
Asthma - Pipeline by Biocon Ltd, H2 2018
Asthma - Pipeline by BiosanaPharma BV, H2 2018
Asthma - Pipeline by Biotec Pharmacon ASA, H2 2018
Asthma - Pipeline by Boehringer Ingelheim GmbH, H2 2018
Asthma - Pipeline by Celon Pharma SA, H2 2018
Asthma - Pipeline by Chiesi Farmaceutici SpA, H2 2018
Asthma - Pipeline by Crossject SA, H2 2018
Asthma - Pipeline by CrystalGenomics Inc, H2 2018
Asthma - Pipeline by CSL Ltd, H2 2018
Asthma - Pipeline by CSPC Pharmaceutical Group Limited, H2 2018
Asthma - Pipeline by Cumberland Pharmaceuticals Inc, H2 2018
Asthma - Pipeline by Cynata Therapeutics Ltd, H2 2018
Asthma - Pipeline by Cytokinetics Inc, H2 2018
Asthma - Pipeline by Daiichi Sankyo Co Ltd, H2 2018
Asthma - Pipeline by Denceptor Therapeutics Ltd, H2 2018
Asthma - Pipeline by Energenesis Biomedical Co Ltd, H2 2018
Asthma - Pipeline by Enterprise Therapeutics Ltd, H2 2018
Asthma - Pipeline by F. Hoffmann-La Roche Ltd, H2 2018
Asthma - Pipeline by FLX Bio Inc, H2 2018
Asthma - Pipeline by Fountain Biopharma Inc, H2 2018
Asthma - Pipeline by Genentech Inc, H2 2018
Asthma - Pipeline by GeneScience Pharmaceuticals Co Ltd, H2 2018
Asthma - Pipeline by GlaxoSmithKline Plc, H2 2018
Asthma - Pipeline by Glenmark Pharmaceuticals Ltd, H2 2018
Asthma - Pipeline by Gossamer Bio Inc, H2 2018
Asthma - Pipeline by Humanigen Inc, H2 2018
Asthma - Pipeline by Hydra Biosciences Inc, H2 2018
Asthma - Pipeline by iCeutica Inc, H2 2018


List Of Figures


Number of Products under Development for Asthma, H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products under Development by Universities/Institutes, H2 2018
Number of Products by Top 10 Targets, H2 2018
Number of Products by Stage and Top 10 Targets, H2 2018
Number of Products by Top 10 Mechanism of Actions, H2 2018
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2018
Number of Products by Top 10 Routes of Administration, H2 2018
Number of Products by Stage and Top 10 Routes of Administration, H2 2018
Number of Products by Top 10 Molecule Types, H2 2018
Number of Products by Stage and Top 10 Molecule Types, H2 2018


Asthma - Pipeline Review, H2 2018

Asthma pipeline review provides an overview of the Asthma (Respiratory) pipeline. Asthma is a chronic disease involving the airways in the lungs.

USD 2500 View Report

Digital Landscape: Asthma

Digital Landscape: AsthmaThe Digital Landscape: Asthma , report analyzes digital activities undertaken by pharma in support of therapies for asthma.Key Highlights- US Patients: Strong feature-rich branded sites for both inhaled and

USD 6000 View Report

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2018

T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - Pipeline Review, H2 2018T Cell Specific Surface Glycoprotein CD28 (TP44 or CD28) - CD28 is a proteins expressed on T

USD 3500 View Report

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2018

Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4 or PSK J3 or CDK4 or EC 2.7.11.22) - Pipeline Review, H2 2018Cyclin Dependent Kinase 4 (Cell Division Protein Kinase 4

USD 3500 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available